Summary
Definition
Anamnesis y examen
Principales factores de diagnóstico
- previous diagnosis of COVID-19 or history of suspected acute COVID-19 illness
Otros factores de diagnóstico
- fatigue/weakness
- cognitive impairment (brain fog)
- impaired sleep
- headache
- dizziness
- dyspnea
- cough
- anosmia/dysgeusia
- pain (including arthralgias and myalgias)
- chest pain
- postexertional malaise
- anxiety/depression
- palpitations
- thirst/dry mouth
- loss of sexual drive or capacity
- numbness/tingling
- hair loss
- gastrointestinal symptoms
Factores de riesgo
- severe COVID-19 illness (requiring hospitalization or ICU admission)
- not vaccinated or only partially vaccinated against COVID-19
- female sex
- age >40 years
- BMI >30 kg/m²
- smoking
- anxiety/depression
- asthma
- chronic kidney disease
- chronic obstructive pulmonary disease (COPD)
- diabetes
- immunosuppression
- ischemic heart disease
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- clinical diagnosis
- complete blood count
- comprehensive metabolic panel
- creatine kinase
- C-reactive protein
- erythrocyte sedimentation rate
- serum ferritin level
- thyroid function tests
- serum 25-hydroxy vitamin D
- pulse oximetry
Pruebas diagnósticas que deben considerarse
- orthostatic testing-tilt table testing
- electrocardiogram
- pulmonary function testing
- chest radiograph
- chest CT
- B-type natriuretic peptide
- D-dimer
- antinuclear antibody
- rheumatoid factor
- anti-cyclic citrulinated peptide
- serum vitamin B12
- blood thiamine
- serum folate
- plasma homocysteine
- high sensitivity troponin
- transthoracic echocardiogram
- ambulatory cardiac monitoring
- cardiac stress test
- cardiopulmonary exercise test
- cardiac MRI
- autonomic function testing
- overnight sleep study
- MRI head
- neuropsychological testing
Algoritmo de tratamiento
all patients
Colaboradores
Autores
Benjamin Abramoff, MD, MS
Assistant Professor of Physical Medicine and Rehabilitation
Perelman School of Medicine
University of Pennsylvania
Philadelphia
PA
Divulgaciones
BA has served on medical advisory boards regarding long COVID for Pfizer, Axcella Pharmaceutical, AstraZeneca, Intrivo Diagnostics, and UnitedHealthcare. BA is an author of references cited in this topic.
Shawn Joshi, MD, PhD
Clinical Resident of Physical Medicine & Rehabilitation
Spaulding Rehabilitation Hospital
Clinical Fellow in Medicine
Harvard Medical School
Boston
MA
Divulgaciones
SJ declares that he has no competing interests.
Eric Herman, MD
Assistant Professor of Family Medicine
School of Medicine
Oregon Health and Science University
Portland
OR
Divulgaciones
EH speaks on evaluation and management of Long COVID nationally. EH is developing educational material for the AAFP. EH has published other manuscripts as part of his current academic role with other leading medical publications.
Agradecimientos
Dr Benjamin Abramoff, Dr Shawn Joshi, and Dr Eric Herman would like to gratefully acknowledge Dr Julie Silver, a previous contributor to this topic.
Divulgaciones
JS has participated in research funded by NIH and foundations on topics not related to COVID-19 including culinary medicine, prehabilitation, and chronic pain. JS is author of references cited in this topic.
Revisores por pares
Sarah Jolley, MD, MSc
Associate Professor
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado
Denver
CO
Divulgaciones
SJ receives NIH funding for work related to long COVID via the RECOVER consortium and AHRQ related to long COVID care delivery.
Trisha Greenhalgh, MA, MD, FRCP, FRCGP, FFPH, PhD
Professor of Primary Care Health Sciences
University of Oxford
Oxford
UK
Divulgaciones
TG is an author of references cited in this topic.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. January 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. COVID-19: clinical overview of long COVID. Feb 2025 [internet publication].Texto completo
Yelin D, Moschopoulos CD, Margalit I, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. 2022 Jul;28(7):955-72.Texto completo Resumen
US Department of Veterans Affairs. Whole health system approach to long COVID: specialty care (nervous system). Sep 2024 [internet publication].Texto completo
US Department of Veterans Affairs. Whole health system approach to long COVID. August 2022 [internet publication].Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
- Post-intensive care syndrome
- Postural orthostatic tachycardia syndrome (POTS)
Más DiferencialesGuías de práctica clínica
- Clinical overview of long COVID
- COVID-19 rapid guideline: managing the long-term effects of COVID-19
Más Guías de práctica clínicaFolletos para el paciente
Anxiety: what are the treatment options?
COVID-19 (coronavirus)
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad